BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2006
View Archived Issues
Preclinical antidementia profile of FK-962
Read More
Antiinflammatory activity of a new SSAO/VAP-1 inhibitor
Read More
Aromatase a target for non-small cell lung cancer treatment
Read More
Oregovomab active in recurrent ovarian cancer
Read More
Encouraging results seen with pegylated arginine deiminase in metastatic melanoma
Read More
Pharmexa sets out development plans for GV-1001
Read More
Nuvelo and Bayer collaborate on alfimeprase
Read More
Aradigm seeks orphan drug designation for liposomal ciprofloxacin
Read More
Analgesic potential of new analogues of valproic acid
Read More
Pivotal phase III study evaluates cethromycin in community-acquired pneumonia
Read More
Zonagen receives IRB approval to begin phase III study of Androxal
Read More
Sangamo and Pfizer expand research collaboration
Read More
CancerVax and Micromet sign merger agreement
Read More
Lilly ruled to have breached oral PTH license agreements with Emisphere
Read More
Grants support work in diabetic kidney disease at University of Virginia
Read More
New therapeutic agents for inflammatory disorders disclosed in recent patents
Read More
VivaGel receives fast track status for HIV prevention
Read More
Thalomid pivotal multiple myeloma trial reaches prespecified interim endpoint
Read More
Bayer reports on the first potent and selective PDE9 inhibitor
Read More
Theravance prepares and tests novel beta2-adrenoceptor agonists for asthma
Read More
FDA approves quarterly intravenous Boniva for postmenopausal osteoporosis
Read More
FDA approval for subcutaneous immunoglobulin treatment Vivaglobin
Read More
NDA submission for CARDIOsphere to assess coronary artery disease
Read More
Taclonex approved for psoriasis vulgaris
Read More
